Hagell Peter, Westergren Albert, Janelidze Shorena, Hansson Oskar
The PRO-CARE Group, School of Health and Society, Kristianstad University, 291 88, Kristianstad, Sweden.
Department of Clinical Sciences, Malmö, Lund University, Lund, Sweden.
Qual Life Res. 2016 Oct;25(10):2571-2577. doi: 10.1007/s11136-016-1318-2. Epub 2016 May 19.
SCOPA-SLEEP is a rating scale for night-time sleep and daytime sleepiness (DS) proposed for use among people with Parkinson's disease (PD) as well as others. We translated it into Swedish and assessed its psychometric properties in PD and age-matched healthy controls.
Following translation according to the dual-panel approach, the Swedish SCOPA-SLEEP was field-tested regarding comprehensibility, relevance and respondent burden (n = 20). It was then psychometrically tested according to classical test theory (data completeness, scaling assumptions, targeting, reliability and construct validity) using data from 149 people with PD and 53 age-matched healthy controls from the prospective Swedish BioFINDER study.
SCOPA-SLEEP took a mean of 3.5 min to complete and was considered easy to use and relevant. Missing item responses were <8 %, corrected item-total correlations were ≥0.47 (except for one DS item among controls), factor analyses suggested one dimension per scale, floor/ceiling effects were ≤17 %, reliability was ≥0.85 except for the DS scale among controls (0.65) and construct validity was supported.
Observations concur with previous evaluations, thus providing initial support for the Swedish SCOPA-SLEEP among people with PD. Further studies are needed to establish its generic properties and to understand its measurement properties in better detail.
SCOPA-睡眠量表是一种用于评估帕金森病(PD)患者及其他人群夜间睡眠和日间嗜睡情况的评定量表。我们将其翻译成瑞典语,并在PD患者和年龄匹配的健康对照中评估其心理测量学特性。
按照双专家组方法进行翻译后,对瑞典版SCOPA-睡眠量表进行了可行性测试,评估其可理解性、相关性和应答负担(n = 20)。然后,根据经典测试理论(数据完整性、量表假设、针对性、信度和结构效度),使用来自前瞻性瑞典生物标志物研究的149例PD患者和53例年龄匹配的健康对照的数据,对该量表进行心理测量学测试。
SCOPA-睡眠量表平均完成时间为3.5分钟,被认为易于使用且相关。缺失条目回答率<8%,校正后的条目-总分相关系数≥0.47(对照组中一个日间嗜睡条目除外),因子分析表明每个量表有一个维度,地板效应/天花板效应≤17%,信度≥0.85(对照组中日间嗜睡量表除外,为0.65),并支持结构效度。
观察结果与先前的评估一致,从而为瑞典版SCOPA-睡眠量表在PD患者中的应用提供了初步支持。需要进一步研究以确定其一般特性,并更详细地了解其测量特性。